NDC 60687-326

Atomoxetine

Atomoxetine

Atomoxetine is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Atomoxetine Hydrochloride.

Product ID60687-326_55b2dcd2-e1fe-1c82-e054-00144ff8d46c
NDC60687-326
Product TypeHuman Prescription Drug
Proprietary NameAtomoxetine
Generic NameAtomoxetine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2017-08-01
Marketing CategoryANDA / ANDA
Application NumberANDA079016
Labeler NameAmerican Health Packaging
Substance NameATOMOXETINE HYDROCHLORIDE
Active Ingredient Strength40 mg/1
Pharm ClassesNorepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 60687-326-25

30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-326-25) > 1 CAPSULE in 1 BLISTER PACK (60687-326-95)
Marketing Start Date2017-08-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60687-326-25 [60687032625]

Atomoxetine CAPSULE
Marketing CategoryANDA
Application NumberANDA079016
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-08-17

NDC 60687-326-95 [60687032695]

Atomoxetine CAPSULE
Marketing CategoryANDA
Application NumberANDA079016
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-08-17

Drug Details

Active Ingredients

IngredientStrength
ATOMOXETINE HYDROCHLORIDE40 mg/1

OpenFDA Data

SPL SET ID:10d36b32-0202-4c03-8a1a-cd5d53f231e7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 349594

    • Pharmacological Class

    • Norepinephrine Reuptake Inhibitor [EPC]
    • Norepinephrine Uptake Inhibitors [MoA]

    Medicade Reported Pricing

    60687032695 ATOMOXETINE HCL 40 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    60687032625 ATOMOXETINE HCL 40 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Atomoxetine" or generic name "Atomoxetine"

    NDCBrand NameGeneric Name
    0093-3542AtomoxetineAtomoxetine
    0093-3543AtomoxetineAtomoxetine
    0093-3544AtomoxetineAtomoxetine
    0093-3545AtomoxetineAtomoxetine
    0093-3546AtomoxetineAtomoxetine
    0093-3547AtomoxetineAtomoxetine
    68382-217atomoxetineatomoxetine
    68382-220atomoxetineatomoxetine
    68382-218atomoxetineatomoxetine
    68382-219atomoxetineatomoxetine
    68382-223atomoxetineatomoxetine
    68382-216atomoxetineatomoxetine
    68462-266atomoxetineatomoxetine
    68462-265atomoxetineatomoxetine
    68462-270atomoxetineatomoxetine
    68462-269atomoxetineatomoxetine
    68462-267atomoxetineatomoxetine
    68462-268atomoxetineatomoxetine
    68462-271atomoxetineatomoxetine
    0093-3548AtomoxetineAtomoxetine
    16714-761atomoxetineatomoxetine
    16714-755atomoxetineatomoxetine
    16714-758atomoxetineatomoxetine
    16714-759atomoxetineatomoxetine
    16714-756atomoxetineatomoxetine
    16714-760atomoxetineatomoxetine
    16714-757atomoxetineatomoxetine
    55111-563AtomoxetineAtomoxetine
    55111-564AtomoxetineAtomoxetine
    55111-520AtomoxetineAtomoxetine
    55111-521AtomoxetineAtomoxetine
    55111-519AtomoxetineAtomoxetine
    55111-522AtomoxetineAtomoxetine
    55111-528AtomoxetineAtomoxetine
    60687-326AtomoxetineAtomoxetine
    64980-375AtomoxetineAtomoxetine
    64980-379AtomoxetineAtomoxetine
    64980-374AtomoxetineAtomoxetine
    64980-376AtomoxetineAtomoxetine
    64980-377AtomoxetineAtomoxetine
    64980-378AtomoxetineAtomoxetine
    64980-373AtomoxetineAtomoxetine
    65862-243AtomoxetineAtomoxetine
    65862-238AtomoxetineAtomoxetine
    65841-608atomoxetineatomoxetine
    65841-607atomoxetineatomoxetine
    65841-610atomoxetineatomoxetine
    65862-239AtomoxetineAtomoxetine
    65862-241AtomoxetineAtomoxetine
    65862-242AtomoxetineAtomoxetine
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.